Issue: Nerac was engaged in order to evaluate acquisition opportunities for a particular type of drug delivery device. The client, a multinational medical device developer and manufacturer, had a goal of generating additional $100 MM annual revenue within 5 years.
Nerac Analyst Approach: Nerac Analysts determined that the client had a strong IP position relative to competitors. In addition, the analysis enabled the client to understand that competitors had few advantages (e.g. manufacturing capacity, international distribution, etc.) that would be worth acquiring.
Client Benefit: Based on Nerac’s recommendations, the client is aggressively pursuing an organic growth strategy which utilizes their strength in low-cost manufacturing and their defendable IP position. Nerac’s assessment allowed the client to realize that an acquisition would provide them with minimal advantages.
Nerac Analyst Approach: Nerac Analysts determined that the client had a strong IP position relative to competitors. In addition, the analysis enabled the client to understand that competitors had few advantages (e.g. manufacturing capacity, international distribution, etc.) that would be worth acquiring.
Client Benefit: Based on Nerac’s recommendations, the client is aggressively pursuing an organic growth strategy which utilizes their strength in low-cost manufacturing and their defendable IP position. Nerac’s assessment allowed the client to realize that an acquisition would provide them with minimal advantages.
